Joint Topic: Rarer H/O Diagnoses — Clinical Pearls of Sirolimus Management for Vascular Anomalies (220-1)

3:30 – 4:30 pm Friday, October 29

Vascular anomalies are a group of disorders and are categorized as either vascular tumors or malformations. Vascular malformations can proliferate and expand, and have clinical sequelae such as chronic pain, disfigurement, infection, coagulopathy, impaired organ function, and decreased quality of life.

Patients with lymphatic and venolymphatic vascular malformations are at risk for these sequelae. Caring for these patients can be a challenge because there are few medical interventions available to them. Treatment is often multimodal and requires the collaboration of a multidisciplinary team. Vascular malformations are not neoplasms, but oftentimes hematology/oncology providers will work in conjunction with multidisciplinary specialists for additional therapy. These patients may undergo many medical interventions, including sclerotherapy and surgical interventions. Sirolimus, a pharmacological agent, can also be used for treatment. The advanced practice registered nurse can provide the necessary support, anticipatory guidance, and education for the use of sirolimus to treat lymphatic and venolymphatic malformations. In this session, we will review several case studies.

Breanne Roche, DNP RN CPNP-PC CPHON®
CNE Hours:
RX Hours: